Medicare
3 articles on Medicare, written by Shotlee and medically reviewed for clinical accuracy.
Supreme Court Ruling: Medicare Drug Price Negotiations Move Forward
In a significant victory for healthcare cost containment, the Supreme Court has allowed Medicare to proceed with negotiating drug prices. This decision upholds a key provision of the Inflation Reduction Act and could impact the cost of many prescription medications, including widely used GLP-1 agonists.
6 min read
Medicare Expands GLP-1 Coverage: What the 2027 Policy Shift Means for Seniors
The federal government has extended its commitment to fund GLP-1 obesity medications through 2027, shifting away from private insurer mandates to protect seniors from premium hikes.
2 min read
Medicare Achieves 71% Discount on Novo's Ozempic and Wegovy
The U.S. government has successfully negotiated a 71% discount on Novo Nordisk's popular drugs Ozempic and Wegovy for Medicare beneficiaries. These price reductions, resulting from recent legislation, will be implemented in 2027, potentially saving millions of dollars.
5 min read